Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Trevi Therapeutics, Inc. (TRVI) had Cash Flow from Financial Activities of $164.58M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-17.80M |
|
-- |
|
-- |
|
$20.51M |
|
$-20.51M |
|
$2.69M |
|
$-17.82M |
|
$-17.82M |
|
$-17.80M |
|
$-17.80M |
|
$-17.80M |
|
$-17.80M |
|
$-20.51M |
|
$-20.48M |
|
156.60M |
|
156.60M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$325.70M |
|
$0.34M |
|
$4.81M |
|
$330.52M |
|
$8.74M |
|
-- |
|
$0.28M |
|
$9.01M |
|
$321.51M |
|
$321.51M |
|
$321.51M |
|
142.42M |
|
| Cash Flow Statement Financials | |
$-34.12M |
|
$-95.07M |
|
|
Cash Flow from Financial Activities |
$164.58M |
$18.91M |
|
$54.30M |
|
$35.39M |
|
$5.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
37.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-34.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.54% |
|
-5.54% |
|
-5.38% |
|
-5.54% |
|
$2.26 |
|
$-0.22 |
|
$-0.22 |
|